BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbulescu CC, Goldstein NB, Roop DR, Norris DA, Birlea SA. Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata. J Invest Dermatol. 2020;140:29-37. [PMID: 31196751 DOI: 10.1016/j.jid.2019.03.1142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Balakirski G, Novak N. Novel therapies and the potential for a personalized approach to atopic dermatitis. Curr Opin Allergy Clin Immunol 2021;21:368-77. [PMID: 34074875 DOI: 10.1097/ACI.0000000000000759] [Reference Citation Analysis]
2 Zhang D, Wei X, Hong W, Fu L, Qian G, Xu AE. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation. Aging (Albany NY) 2021;13:5415-25. [PMID: 33582653 DOI: 10.18632/aging.202472] [Reference Citation Analysis]
3 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Vocetkova K, Sovkova V, Buzgo M, Lukasova V, Divin R, Rampichova M, Blazek P, Zikmund T, Kaiser J, Karpisek Z, Amler E, Filova E. A Simple Drug Delivery System for Platelet-Derived Bioactive Molecules, to Improve Melanocyte Stimulation in Vitiligo Treatment. Nanomaterials (Basel) 2020;10:E1801. [PMID: 32927642 DOI: 10.3390/nano10091801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Macaluso FS, Rodríguez-lago I. JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease. CDM 2020;21:247-55. [DOI: 10.2174/1389200221666200310111409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Ann Rheum Dis 2021;80:71-87. [PMID: 33158881 DOI: 10.1136/annrheumdis-2020-218398] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 24.0] [Reference Citation Analysis]
7 Wang Y, Li S, Li C. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo. Clin Rev Allergy Immunol 2021. [PMID: 34283349 DOI: 10.1007/s12016-021-08868-z] [Reference Citation Analysis]
8 Li Y, Ye Z, Yang W, Zhang Q, Zeng J. An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases. Stem Cells Int 2021;2021:8834590. [PMID: 33505474 DOI: 10.1155/2021/8834590] [Reference Citation Analysis]